Preface: Zebrafish Models of Neurology  by Allison, W. Ted
Biochimica et Biophysica Acta 1812 (2011) 333–334
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r.com/ locate /bbad isEditorial
Preface: Zebraﬁsh Models of Neurology☆Forming hypotheses about the Molecular Basis of Neurological
Disease has traditionally been based on human genetics, biochemistry
and molecular biology, whereas testing these hypotheses requires us
to turn to cell culture and animal models. Zebraﬁsh have emerged as a
tractable platform to complement and bridge these paradigms in
many diseases, allowing integration of human genetics and cell
biology within the in vivo setting. Perhaps it is in Neurology and
Neurodegeneration, however, where zebraﬁsh have special promise
to make contributions. Four special advantages of zebraﬁsh to
Neurology are worth highlighting here: efﬁcient in vivo tests for
genetic interactions, conserved cellular architecture of the CNS, the
ability to create genetically mosaic animals, and tractable behaviour
and electrophysiology to assess experimental interventions.
Linkages between Neurodegenerative diseases that were once
considered distinct are being recognized and celebrated as a path
forward to understanding the molecular basis of disease spread
through the CNS. One example includes interactions between
notorious proteins in Alzheimer Disease (AD) and Prion Disease,
such that the Prion Protein may now be viewed as a receptor for Aβ
oligomers. The abundance of such interactions between Neurological
Diseases is growing, as protein interactome studies identify many
players in common, compelling the ﬁeld to integrate an increasing list
of genetic interactions into their models. The ability to efﬁciently
knockdown and overexpress gene products in vivo is propelling
zebraﬁsh to prominence at a rate commensurate with the complexity
of these genetic interactions.
On the other hand, various researchers have recently noted
intriguing parallels between prion diseases and the protein misfolding
in other neurological diseases. In particular, questions are being raised
as to the ability of misfolded proteins (including Tau and Aβ) to induce
the misfolding of normally folded protein, leading to a prion-like
domino effect and accumulation of protein dysfunction/aggregation
that are hallmark disease pathologies. Consistent with such ﬁndings is
the apparent spreading of disease pathology from a nucleation centre
through the CNS during clinical disease progression. Other celebrated
potential prion-like proteins include α-synuclein, polyglutamine
proteins and SOD1 misfolding in ALS.
Attention toward this prionoid nature of various neurological
diseases is substantial, in large part because it identiﬁes a novel
therapeutic target: the mechanism of disease spreading. Unfortu-
nately, the ﬁeld knows remarkably little about disease spreading, with
concepts in high-proﬁle reviews centering on Tunneling Nanotubes
and exosome or synaptic release. Perhaps this fundamental lack of
knowledge regarding disease spread through the CNS is the
consequence of the tools available to neurologists and neuroscience
researchers. The mechanisms underlying AD, TSEs, and ALS have☆ This article is part of a Special Issue entitled Zebraﬁsh Models of Neurological
Diseases.
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aggregation, cell culture work and mouse models; These paradigms
are challenging to implement in a fashion that tells us how disease in
one portion of the CNS spreads to another. Zebraﬁsh are positioned
brilliantly to ﬁll this gap, not only because of its efﬁciency as a genetic
and neuroscience model, but because zebraﬁsh have a long history as
a platform for assessing non-cell-autonomous effects of protein
perturbations in the in vivo setting. Thus it is common for zebraﬁsh
biologists to ask if changing gene abundance or character in one group
of neurons is able to affect the fate and function of neighboring cells.
Creative and ambitious deployment of this ability will complement
established tools to promise a deep understanding of how disease
spreads between cells. A tantalizing side-beneﬁt is the ability to
deploy the ﬁsh in high-throughput screens of protein and small
molecule effectors that represent therapeutic targets.
Finally, it is important to underline the cellular context of disease
spreading during Neurolodegeneration. As disease spreads from cell
to cell, the molecular basis of this spread is fundamentally inﬂuenced
by the cellular relationships. Importantly, The zebraﬁsh has an
architecture of CNS cells that is conserved with that of humans.
Vasculature, blood-brain-barriers, and ventricles are all present from
a young age, permitting tissue-level spread of molecules fundamental
to disease. Perhaps more importantly, the cells of the CNS develop in
their normal environment, becoming polarized, interconnected and
ensheathed in radial glia to form ion sinks. The cover image selected is
meant to highlight that this organization exists even in young
embryos. Certainly our understanding of hallmark synaptic dysfunc-
tion during Neurodegeneration must develop from paradigms where
synapses are formed and maintained with their typical glial partners
intact. So although zebraﬁsh is not yet as advanced in its toolkit as
Drosophila, nor as tractable as cell culture, it has a relevant cellular
architecture and genetic efﬁciency that make the paradigm a very
attractive in vivo complement to studies in mouse models.
This issue of BBA: Molecular Basis of Disease has invited reviews
from leading experts to consider the utility of zebraﬁsh to Neurology.
These experts span from Neuroscientists who study fundamentals of
zebraﬁsh Biology, through to clinical Neurologists who recognize the
zebraﬁsh as a relevant and potent paradigm to bring their hypotheses
to bedside in as timely a manner as possible. The ﬁrst contributions
have sought to critically analyze previous work regarding particular
Neurodegenerative diseases and how zebraﬁsh have contributed to
this understanding. The subsequent contributions consider technical
opportunities and challenges of using zebraﬁsh genetics and beha-
vioural outputs in Neurology, and the issue ends with the promise
provided by zebraﬁsh to understand regeneration of the CNS for
repair.
I am grateful to each of these contributors, reviewers, and the
BBA staff for their hardwork in communicating these important and
stimulating ideas.
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